Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Long-term safety of risperidone
M. Davidson
*
*
Corresponding author for this work
Abarbanel Mental Health Center
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Long-term safety of risperidone'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Risperidone
100%
Long-term Safety
100%
Adverse Events
50%
Clinical Trials
25%
Clinically Significant
25%
Placebo
25%
Tardive Dyskinesia
25%
Treatment Group
25%
Dementia
25%
Tolerability
25%
Vital Signs
25%
Pivotal Trial
25%
Clinical Dose
25%
Laboratory Signs
25%
Open-label Extension
25%
Pharmacology, Toxicology and Pharmaceutical Science
Risperidone
100%
Adverse Event
50%
Clinical Trial
25%
Placebo
25%
Tardive Dyskinesia
25%
Tolerability
25%